# Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase

> **NCT07320534** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Gadjah Mada University** · enrollment: 124 (estimated)

## Conditions studied

- Neutropenic Fever
- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Levofloxacin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07320534
- **Lead sponsor:** Gadjah Mada University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07320534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07320534, "Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07320534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*